Protara Therapeutics (TARA) Other Non Operating Income (2013 - 2025)

Protara Therapeutics (TARA) posted quarterly Other Non Operating Income of $249000.0 for Q4 2025, down 48.23% quarter-over-quarter from $481000.0 in Q1 2025.

Protara Therapeutics (TARA) Other Non Operating Income (2013 - 2025) Analysis & Trends

Protara Therapeutics (TARA) has reported Other Non Operating Income for 8 consecutive years, with $249000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Other Non Operating Income changed N/A year-over-year to $249000.0; the TTM figure through Dec 2025 stood at $730000.0 (changed N/A YoY), while the FY2025 annual figure was $730000.0, up 88.63% from the prior year.
  • Other Non Operating Income slipped to $249000.0 in Q4 2025 per TARA's latest filing, from $481000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $481000.0 in Q1 2025 and bottomed at $249000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Protara Therapeutics 234.56 Mn 234.56 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 249,000.00
Mar 31, 2025 481,000.00
Sep 30, 2019 2,000.00
Jun 30, 2019 -2,000.00
Mar 31, 2019 1,000.00
Sep 30, 2018 -1,000.00
Jun 30, 2018 15,000.00
Mar 31, 2018 192,000.00
Sep 30, 2017 -84,000.00
Jun 30, 2017 332,000.00
Mar 31, 2017 -50,000.00
Sep 30, 2016 -4,000.00
Jun 30, 2016 -63,000.00
Mar 31, 2016 6,000.00
Dec 31, 2015 4.65 Mn
Sep 30, 2015 -335,000.00
Jun 30, 2015 -14,000.00
Dec 31, 2014 10.50 Mn
Sep 30, 2014 -5.33 Mn
Jun 30, 2014 -29,000.00